De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Ipca Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Ipca Laboratories heeft een totaal eigen vermogen van ₹77.3B en een totale schuld van ₹14.4B, wat de schuld-eigenvermogensverhouding op 18.6% brengt. De totale activa en totale passiva bedragen respectievelijk ₹111.0B en ₹33.7B. De EBIT Ipca Laboratories is ₹9.9B waardoor de rentedekking 14.7 is. Het heeft contanten en kortetermijnbeleggingen van ₹8.5B.
Belangrijke informatie
18.6%
Verhouding schuld/eigen vermogen
₹14.38b
Schuld
Rente dekkingsratio | 14.7x |
Contant | ₹8.54b |
Aandelen | ₹77.27b |
Totaal verplichtingen | ₹33.74b |
Totaal activa | ₹111.01b |
Recente financiële gezondheidsupdates
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15Recent updates
Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)
Sep 10Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively
Jun 07Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing
May 24Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings
Feb 07Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)
Aug 31Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)
May 28Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well
Sep 20Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Aug 09Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Jun 08How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?
Mar 26Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?
Mar 13Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently
Feb 28Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?
Feb 11Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?
Jan 30The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It
Jan 15Ipca Laboratories (NSE:IPCALAB) Seems To Use Debt Rather Sparingly
Dec 31Don't Ignore The Fact That This Insider Just Sold Some Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Dec 16The Case For Ipca Laboratories Limited (NSE:IPCALAB): Could It Be A Nice Addition To Your Dividend Portfolio?
Dec 13Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹55.4B ) IPCALAB } overtreffen de korte termijn passiva ( ₹23.6B ).
Langlopende schulden: De kortetermijnactiva IPCALAB ( ₹55.4B ) overtreffen de langetermijnschulden ( ₹10.2B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 7.6% ) IPCALAB wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van IPCALAB is de afgelopen 5 jaar gestegen van 14.8% naar 18.6%.
Schuldendekking: De schuld van IPCALAB wordt goed gedekt door de operationele kasstroom ( 65.7% ).
Rentedekking: De rentebetalingen op de schuld van IPCALAB worden goed gedekt door EBIT ( 14.7 x dekking).